Phase 3,Placebo Controlled,Randomized,Double-Blinded,NSAID-Add-on,Clinical Trial of Mono-Phase Low Dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.

Trial Profile

Phase 3,Placebo Controlled,Randomized,Double-Blinded,NSAID-Add-on,Clinical Trial of Mono-Phase Low Dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2010

At a glance

  • Drugs Ethinylestradiol/norethisterone (Primary)
  • Indications Dysmenorrhoea; Endometriosis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 06 Sep 2010 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
    • 06 Sep 2010 Actual initiation date (December 2004) and actual patient number (100) added as reported by ClinicalTrials.gov.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top